Cargando…
Angiogenin—A Proposed Biomarker for Cardiovascular Disease—Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease
We evaluated angiogenin as a prospective biomarker in peripheral artery disease (PAD) patients with and without claudication symptoms. A pilot study suggested an elevation of angiogenin in critical limb ischemia. However, in PAD patients, the predictive value of angiogenin has not yet been evaluated...
Autores principales: | Höbaus, Clemens, Pesau, Gerfried, Zierfuss, Bernhard, Koppensteiner, Renate, Schernthaner, Gerit-Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436295/ https://www.ncbi.nlm.nih.gov/pubmed/33779308 http://dx.doi.org/10.1177/00033197211004393 |
Ejemplares similares
-
Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes
por: Zierfuss, Bernhard, et al.
Publicado: (2019) -
NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype
por: Zierfuss, Bernhard, et al.
Publicado: (2023) -
Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control
por: Höbaus, Clemens, et al.
Publicado: (2020) -
Vascular peroxidase 1 is independently associated with worse kidney function in patients with peripheral artery disease
por: Costas, Lavinia, et al.
Publicado: (2020) -
Arterial stiffness in childhood: A predictor for later cardiovascular disease?
por: Ahmadizar, Fariba, et al.
Publicado: (2017)